Starch-Based Excipient for Direct Compression
StarTab from Colorcon was designed to ensure functionality and stability for direct compression tableting.
Colorcon has introduced StarTab, a starch tableting excipient designed for the direct compression process. The excipient’s particle size and shape are designed to improve flow and compressibility on high-speed compression machines; enabling formulation scientists to simplify tablet formulation and manufacturing, the company reports in a May 16, 2019 press statement.
The excipient also is formulated to enhance the stability of moisture-sensitive APIs.
The company reports that StarTab uses material that is accepted by global regulatory authorities, reducing barriers to adoption of the product.
Source: Colorcon, Inc.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Hesperos, Psilera Agree to Accelerate Organ-on-a-Chip Treatment for Frontotemporal Dementia
June 9th 2025The partnership leverages the Hesperos organ-on-a-chip platform in the preclinical development of Psilera’s lead compound targeting the progressive neurological disorder for which treatment options are few.
